Pharma-Bio Serv (PBSV) Short Interest Ratio & Short Volume → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free PBSV Stock Alerts $0.75 +0.01 (+2.03%) (As of 05/3/2024 11:45 AM ET) Add Compare Share Share Short InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartDividendEarningsFinancialsHeadlinesSEC FilingsShort Interest Pharma-Bio Serv Short Interest DataCurrent Short Volume4,200 sharesPrevious Short Volume4,200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$4,410.00Short Interest Ratio / Days to Cover0.7Last Record DateJanuary 15, 2024Outstanding Shares22,960,000 sharesPercentage of Shares Shorted0.02%Today's Trading Volume4,001 sharesAverage Trading Volume1,442 sharesToday's Volume Vs. Average277% Short Selling Pharma-Bio Serv ? Sign up to receive the latest short interest report for Pharma-Bio Serv and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPBSV Short Interest Over TimePBSV Days to Cover Over TimePBSV Percentage of Float Shorted Over Time Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Pharma-Bio Serv Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/20244,200 shares $4,410.00 No ChangeN/A0.7 $1.05 12/31/20234,200 shares $4,410.00 No ChangeN/A0.3 $1.05 12/15/20234,200 shares $4,179.00 -10.6%N/A0.8 $1.00 11/30/20234,700 shares $4,183.00 No ChangeN/A0.4 $0.89 11/15/20234,700 shares $4,606.00 +42.4%N/A0.7 $0.98 10/31/20233,300 shares $2,804.01 No ChangeN/A0.6 $0.85 Get the Latest News and Ratings for PBSV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter. 10/15/20233,300 shares $3,036.00 No ChangeN/A1.9 $0.92 9/30/20233,300 shares $3,399.00 No ChangeN/A2.4 $1.03 9/15/20233,300 shares $3,300.00 -21.4%N/A0.9 $1.00 8/31/20234,200 shares $4,284.00 +4,100.0%N/A0.9 $1.02 8/15/2023100 shares $100.00 No ChangeN/A0 $1.00 7/31/2023100 shares $107.40 No ChangeN/A0.1 $1.07 7/15/2023100 shares $84.00 No ChangeN/A0 $0.84 6/30/2023100 shares $89.50 -50.0%N/A0.1 $0.90 6/15/2023200 shares $176.00 +100.0%N/A0.1 $0.88 5/31/2023100 shares $80.00 -95.2%N/A0 $0.80 5/15/20232,100 shares $2,037.21 +425.0%N/A0.3 $0.97 4/30/2023400 shares $408.00 -55.6%N/A0.1 $1.02 4/15/2023900 shares $846.00 -47.1%N/A0.3 $0.94 3/31/20231,700 shares $1,589.50 No ChangeN/A0.1 $0.94 6/15/2022700 shares $671.93 No ChangeN/A0.1 $0.96 12/31/20212,000 shares $2,060.00 No ChangeN/A0.2 $1.03 10/29/2021100 shares $103.00 No ChangeN/A0 $1.03 10/15/2021100 shares $106.00 -50.0%N/A0 $1.06 9/30/2021200 shares $202.00 No ChangeN/A0 $1.01 8/31/2021100 shares $115.00 No ChangeN/A0 $1.15 8/13/2021100 shares $114.00 No ChangeN/A0 $1.14 6/15/2021100 shares $123.00 No ChangeN/A0 $1.23 4/15/2021100 shares $125.00 No ChangeN/A0 $1.25 3/31/2021100 shares $123.00 -50.0%N/A0 $1.23 3/15/2021200 shares $302.00 No ChangeN/A0 $1.51 2/26/2021200 shares $300.00 No ChangeN/A0 $1.50 1/29/2021100 shares $135.00 No ChangeN/A0 $1.35 11/15/2020100 shares $134.00 No ChangeN/A0 $1.34 10/30/2020100 shares $128.00 -75.0%N/A0 $1.28 10/15/2020400 shares $572.00 +300.0%N/A0.1 $1.43 9/30/2020100 shares $129.00 No ChangeN/A0 $1.29 9/15/2020100 shares $117.00 No ChangeN/A0 $1.17 7/31/2020100 shares $100.00 -50.0%N/A0 $1.00 7/15/2020200 shares $188.00 -66.7%N/A0 $0.94Could Your Accounts Be Frozen? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit PBSV Short Interest - Frequently Asked Questions What is Pharma-Bio Serv's current short interest? Short interest is the volume of Pharma-Bio Serv shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 4,200 shares of PBSV short. Learn More on Pharma-Bio Serv's current short interest. What is a good short interest ratio for Pharma-Bio Serv? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PBSV shares currently have a short interest ratio of 1.0. Learn More on Pharma-Bio Serv's short interest ratio. How does Pharma-Bio Serv's short interest compare to its competitors? Here is how the short interest of companies in the sector of "business services" compare to Pharma-Bio Serv: Castellum, Inc. (0.39%), ATIF Holdings Limited (0.56%), Ryvyl Inc. (1.45%), Aeries Technology, Inc (0.77%), Singularity Future Technology Ltd. (2.14%), Aterian, Inc. (8.05%), Presto Automation Inc. (3.63%), Skillful Craftsman Education Technology Limited (0.07%), MicroCloud Hologram Inc. (42.90%), DIAGNOS Inc. (0.05%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks. What does it mean to sell short Pharma-Bio Serv stock? Short selling PBSV is an investing strategy that aims to generate trading profit from Pharma-Bio Serv as its price is falling. PBSV shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pharma-Bio Serv? A short squeeze for Pharma-Bio Serv occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PBSV, which in turn drives the price of the stock up even further. How often is Pharma-Bio Serv's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBSV, twice per month. The most recent reporting period available is January, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Castellum Short Interest Data ATIF Short Interest Data Ryvyl Short Interest Data Aeries Technology Short Interest Data Singularity Future Technology Short Interest Data Aterian Short Interest Data Presto Automation Short Interest Data Skillful Craftsman Education Technology Short Interest Data MicroCloud Hologram Short Interest Data DIAGNOS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:PBSV) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace